CCM
CME icon

Cantillon Capital Management’s CME Group CME Stock Holding History

Cantillon Capital Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409M Sell
1,386,346
-186,671
-12% -$55.4M 2.72% 13
2025
Q4 		$430M Buy
1,573,017
+11,844
+0.8% +$3.22M 2.32% 18
2025
Q3 		$422M Sell
1,561,173
-17,177
-1% -$4.67M 2.32% 21
2025
Q2 		$435M Sell
1,578,350
-45,856
-3% -$12.5M 2.51% 17
2025
Q1 		$431M Sell
1,624,206
-50,232
-3% -$12.4M 2.79% 17
2024
Q4 		$389M Buy
1,674,438
+9,622
+0.6% +$2.21M 2.35% 19
2024
Q3 		$367M Sell
1,664,816
-50,497
-3% -$10.4M 2.25% 20
2024
Q2 		$337M Sell
1,715,313
-87,278
-5% -$18M 2.25% 19
2024
Q1 		$388M Sell
1,802,591
-36,107
-2% -$7.58M 2.44% 23
2023
Q4 		$387M Sell
1,838,698
-44,368
-2% -$9.47M 2.59% 18
2023
Q3 		$377M Sell
1,883,066
-6,960
-0.4% -$1.38M 2.8% 15
2023
Q2 		$350M Buy
1,890,026
+113,463
+6% +$21M 2.45% 19
2023
Q1 		$340M Buy
1,776,563
+189,319
+12% +$34.2M 2.77% 16
2022
Q4 		$267M Sell
1,587,244
-27,418
-2% -$4.76M 2.26% 22
2022
Q3 		$286M Sell
1,614,662
-14,374
-0.9% -$2.84M 2.59% 16
2022
Q2 		$333M Sell
1,629,036
-7,226
-0.4% -$1.53M 2.78% 15
2022
Q1 		$389M Buy
1,636,262
+44,806
+3% +$10.5M 2.78% 16
2021
Q4 		$364M Sell
1,591,456
-119,147
-7% -$26.2M 2.4% 21
2021
Q3 		$331M Sell
1,710,603
-26,537
-2% -$5.38M 2.26% 25
2021
Q2 		$369M Sell
1,737,140
-21,749
-1% -$4.59M 2.49% 21
2021
Q1 		$359M Sell
1,758,889
-58,173
-3% -$11.5M 2.62% 21
2020
Q4 		$331M Sell
1,817,062
-17,516
-1% -$2.98M 2.48% 19
2020
Q3 		$307M Sell
1,834,578
-18,491
-1% -$3.11M 2.57% 16
2020
Q2 		$301M Buy
1,853,069
+18,660
+1% +$3.34M 2.62% 18
2020
Q1 		$317M Sell
1,834,409
-3,765
-0.2% -$749K 3.51% 11
2019
Q4 		$369M Sell
1,838,174
-40,821
-2% -$8.37M 3.43% 12
2019
Q3 		$397M Sell
1,878,995
-9,103
-0.5% -$1.9M 3.86% 11
2019
Q2 		$366M Sell
1,888,098
-38,706
-2% -$7.14M 3.7% 11
2019
Q1 		$317M Sell
1,926,804
-9,358
-0.5% -$1.65M 3.37% 12
2018
Q4 		$364M Buy
1,936,162
+13,400
+0.7% +$2.47M 4.4% 6
2018
Q3 		$327M Sell
1,922,762
-127,986
-6% -$21.5M 3.68% 11
2018
Q2 		$336M Sell
2,050,748
-57,982
-3% -$9.47M 3.62% 14
2018
Q1 		$341M Sell
2,108,730
-43,506
-2% -$6.93M 3.88% 12
2017
Q4 		$314M Sell
2,152,236
-148,786
-6% -$21.2M 3.72% 13
2017
Q3 		$312M Sell
2,301,022
-66,232
-3% -$8.37M 3.63% 13
2017
Q2 		$296M Sell
2,367,254
-101,900
-4% -$12.2M 3.7% 14
2017
Q1 		$293M Sell
2,469,154
-16,984
-0.7% -$2.04M 3.75% 14
2016
Q4 		$287M Sell
2,486,138
-82,900
-3% -$9.23M 4.02% 13
2016
Q3 		$269M Sell
2,569,038
-7,800
-0.3% -$814K 3.79% 13
2016
Q2 		$251M Buy
2,576,838
+113,000
+5% +$10.7M 4.23% 12
2016
Q1 		$237M Sell
2,463,838
-99,767
-4% -$9.08M 4.14% 13
2015
Q4 		$232M Buy
2,563,605
+963,568
+60% +$90.7M 4.37% 12
2015
Q3 		$148M Buy
1,600,037
+143,237
+10% +$13.6M 3.16% 14
2015
Q2 		$136M Sell
1,456,800
-41,500
-3% -$3.87M 2.71% 15
2015
Q1 		$142M Sell
1,498,300
-4,700
-0.3% -$435K 2.78% 15
2014
Q4 		$133M Buy
+1,503,000
New +$127M 2.75% 14

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cantillon Capital Management's CME Position: Q1 2026 in Review

Cantillon Capital Management reduced its CME Group (CME) stake by 12% in Q1 2026, selling an estimated $55.4M and leaving 1,386,346 shares worth $409M. The position accounts for 2.72% of the portfolio, ranked #13.

Cantillon Capital Management first reported a position in CME in Q4 2014 and has held it in 46 quarters since. The position peaked at $435M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Cantillon Capital Management held 1,386,346 shares of CME Group worth $409M as of Q1 2026.
  • Cantillon Capital Management sold 186,671 CME Group shares in Q1 2026, an estimated $55.4M.
  • CME Group made up 2.72% of Cantillon Capital Management's portfolio in Q1 2026, its #13 holding.
  • Cantillon Capital Management first reported a position in CME Group in Q4 2014 and has held it in 46 quarters since.
  • Cantillon Capital Management's CME Group position peaked at $435M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Cantillon Capital Management's 13F filing for Q1 2026, filed 7 May 2026.